Doris Taylor’s groundbreaking U of M research on how to build hearts and other organs is now the core of a fledging start-up, Miromatrix. It could be a sign that technology transfer at the university is improving. And while the company doesn’t own a mailbox today, tomorrow, some believe, it could spawn a whole new med-tech industry.
